
Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc. (CTNM)
WebsitePrice
Market cap
Next catalystEstimated PROPEL-IPF completion in June 2028, based on enrollment to date at clinical sitesPIPE-791 — PROPEL-IPF · Study completionSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
Partner / License out
History / paused
PreINDP1P2P3FilingApproved